文献速递疼痛医学神经外科与老年麻醉

脊髓BAF在神经病理性疼痛中表观沉默μ阿片受体基因的作用

Role of spinal Barrier-to-Autointegration Factor (BAF) in the epigenetic silencing of the mu-opioid receptor gene in neuropathic pain.
PubMed 文献 · Reg Anesth Pain Med · 2026-03-05

该研究在大鼠脊髓神经结扎模型中发现,神经损伤升高脊髓背角BAF水平,BAF与LEMD2互作激活EZH2,在Oprm1启动子添加H3K27me3沉默标记,使μ阿片受体表达下降。敲低BAF或LEMD2、抑制EZH2均可逆转上述信号并减轻机械性痛觉超敏,提示pNR2B-BAF-LEMD2-EZH2通路是潜在干预靶点。

要点

  • 神经损伤后脊髓BAF升高,通过LEMD2-EZH2轴沉默Oprm1基因。
  • 敲低BAF可逆转SNL诱导的μ阿片受体下降并减轻机械性痛觉超敏。
  • NR2B受体阻断可逆转谷氨酸对BAF通路的激活。

核心结论

  • 脊髓pNR2B受体可能激活BAF,BAF与LEMD2互作增强EZH2介导的μ阿片受体启动子H3K27me3,神经损伤后沉默Oprm1基因。
  • 靶向该通路可能为抑制神经病理性疼痛提供新策略。

研究设计与样本

  • 成年Sprague-Dawley大鼠行脊髓神经结扎(SNL)建立神经病理性疼痛模型。
  • 采用von Frey和burrow测试评估疼痛行为,并检测脊髓背角mRNA与蛋白表达。

主要发现

  • SNL升高BAF水平,BAF与LEMD2互作激活组蛋白修饰酶EZH2。
  • EZH2在Oprm1启动子添加H3K27me3沉默标记,使μ阿片受体表达下降。
  • 敲低BAF逆转SNL诱导的LEMD2、EZH2和μ阿片受体表达变化并减轻机械性痛觉超敏。
  • 敲低LEMD2破坏BAF与Oprm1启动子结合而不影响BAF水平;抑制EZH2逆转信号而不改变BAF和LEMD2水平。
  • 谷氨酸经pNR2B受体激活BAF通路,NR2B受体阻断可逆转该效应。

临床怎么用

  • 神经病理性疼痛中脊髓μ阿片受体表达下降可能与BAF-LEMD2-EZH2表观沉默通路相关。
  • pNR2B受体、BAF、LEMD2和EZH2构成潜在干预靶点,尚需进一步转化研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuropathic pain presents a significant clinical challenge, with spinal cord epigenetic mechanisms playing a critical role in its development. This study investigated the impact of nerve injury on the Barrier-to-Autointegration Factor (BAF) in the rat spinal dorsal horn. METHODS: Adult Sprague-Dawley rats underwent spinal nerve ligation (SNL) to model neuropathic pain. Pain behaviors were assessed using von Frey and burrow tests. Biochemical analyses measured mRNA and protein expression in the dorsal horn. RESULTS: SNL elevated BAF levels, which interacts with LEM domain-containing protein 2 (LEMD2), activating the histone-modifying enzyme EZH2. This enzyme adds a gene-silencing mark, H3K27me3, to the promoter region of the Oprm1 gene, which encodes the mu-opioid receptor. Consequently, the expression of the mu-opioid receptor is decreased, potentially contributing to neuropathic pain. Using gene knockdown techniques to reduce BAF expression, we reversed the changes in LEMD2, EZH2, and mu-opioid receptor expressions induced by SNL and attenuated mechanical allodynia. Additionally, knocking down LEMD2 disrupted the binding of BAF to the Oprm1 promoter, without affecting BAF levels. Inhibiting EZH2 also reversed the signaling without altering BAF and LEMD2 levels. Glutamate activated BAF pathways via pNR2B receptors, and NR2B receptor blockade reversed this effect. CONCLUSION: These findings suggest that spinal pNR2B receptors may activate BAF, which interacts with LEMD2 to enhance EZH2-mediated H3K27me3 at the mu-opioid receptor promoter after nerve injury. Targeting this pathway may offer novel strategies to inhibit neuropathic pain.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Hsieh MC, Lai CY, Lin TB, et al. Role of spinal Barrier-to-Autointegration Factor (BAF) in the epigenetic silencing of the mu-opioid receptor gene in neuropathic pain. Reg Anesth Pain Med. 2026. PMID: 39915245. doi:10.1136/rapm-2024-106004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。